Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current diagnostic guidelines for Alzheimer's disease.

R W Hamill1, D M Pilgrim

  • 1Medical Center Hospital of Vermont, Burlington, USA.

Contemporary Internal Medicine
|April 8, 1995
PubMed
Summary

This review outlines a step-by-step approach for diagnosing Alzheimer's disease. It emphasizes the importance of neurological exams and cognitive screening as the first steps in diagnosis. The authors recommend using tools like the MMSE to detect cognitive decline. They also highlight the need to assess mood changes to rule out depression. Laboratory tests are suggested to exclude other causes of cognitive issues. Imaging studies should be used selectively, especially in cases with unclear symptoms. The review concludes that a structured diagnostic pathway improves accuracy and early detection. The authors propose that guidelines should be updated to reflect these findings.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatitis C virus infection: a risk factor for Parkinson's disease.

Journal of viral hepatitis·2016
Same author

Central regulation of sympathetic ganglia development: heterogeneous response of paravertebral, prevertebral, and terminal ganglia.

Annals of the New York Academy of Sciences·1998
Same author

Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons.

Archives of neurology·1997
Same author

Weight loss in people with Alzheimer's disease: a prospective population based analysis.

BMJ (Clinical research ed.)·1997
Same author

Effect of buthionine sulfoximine, a synthesis inhibitor of the antioxidant glutathione, on the murine nigrostriatal neurons.

Journal of neurochemistry·1996
Same author

Prevalence of parkinsonian signs and associated mortality in a community population of older people.

The New England journal of medicine·1996

Area of Science:

  • Neurology diagnostic protocols
  • Cognitive assessment methodologies
  • Geriatric health evaluation

Background:

Current knowledge about Alzheimer's diagnosis includes the use of standardized tools to detect cognitive and physical changes. However, gaps remain in how to integrate these tools into a cohesive diagnostic framework. Prior research has established the importance of neurological exams and cognitive screening. No prior work had resolved the best timing for imaging studies. That uncertainty drove this review to clarify when and how to apply these methods. This gap motivated the authors to synthesize existing guidelines into actionable steps. The uncertainty around mood assessment in Alzheimer's remains unresolved. This review aims to address how mood changes can be systematically evaluated. The challenge lies in distinguishing Alzheimer's from other neurodegenerative conditions. This uncertainty highlights the need for precise diagnostic criteria.

Purpose Of The Study:

This review seeks to outline a structured approach for diagnosing Alzheimer's disease. The specific problem is the lack of consensus on when to use imaging and how to assess mood changes. The motivation comes from the need to standardize diagnostic practices across clinics. The authors aim to clarify the role of physical exams in Alzheimer's detection. They also want to highlight the most effective cognitive assessment tools. The study focuses on when laboratory tests should be prioritized. The goal is to provide a diagnostic framework that reduces variability in diagnosis. The authors emphasize the importance of early detection through structured exams.

Keywords:
Alzheimer's diagnosiscognitive screeningneurological examsmood assessment in dementia

Frequently Asked Questions

The main outcome is a structured diagnostic pathway that includes neurological exams and cognitive screening.

The authors suggest using the Mini-Mental State Examination (MMSE) for cognitive screening.

Imaging studies should be reserved for cases with atypical symptoms or diagnostic uncertainty.

Laboratory tests help exclude other causes of cognitive decline, such as vitamin deficiencies.

Mood assessment is recommended to rule out depression and differentiate it from Alzheimer's.

Related Experiment Videos

Main Methods:

The authors conducted a review of existing diagnostic guidelines for Alzheimer's disease. They analyzed the use of neurological exams and cognitive screening tools. They evaluated the role of mood assessment in the diagnostic process. The study included a review of laboratory tests commonly used in Alzheimer's diagnosis. The authors examined when imaging studies should be introduced in the diagnostic pathway. They compared different assessment instruments for detecting cognitive dysfunction. The review approach included synthesizing findings from multiple clinical guidelines. The authors focused on identifying best practices for early detection.

Main Results:

The review suggests that neurological exams should be the first step in Alzheimer's diagnosis. It recommends using standardized cognitive screening tools like the MMSE. The findings indicate that mood assessment is essential for ruling out depression. Laboratory tests should be used to exclude other causes of cognitive decline. The authors propose that imaging studies should be reserved for cases with atypical symptoms. The review highlights the importance of physical exams in detecting early signs. The strongest finding is the need for a structured diagnostic pathway. The authors suggest that early detection improves patient outcomes.

Conclusions:

The authors conclude that a structured diagnostic approach improves Alzheimer's detection accuracy. They propose that neurological exams and cognitive screening should be prioritized. The review suggests that mood changes should be systematically assessed. The authors highlight the role of laboratory tests in ruling out other conditions. They emphasize that imaging should be used selectively, not routinely. The synthesis indicates that early detection is possible with standardized tools. The authors suggest that diagnostic guidelines should be updated to reflect these findings. The implications are that a consistent approach can reduce diagnostic delays.

The authors suggest that a structured diagnostic approach improves detection accuracy and reduces delays.